Clinical Trials Logo

Tricuspid Valve Insufficiency clinical trials

View clinical trials related to Tricuspid Valve Insufficiency.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05130775 Withdrawn - Clinical trials for Tricuspid Regurgitation

Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography

Start date: August 5, 2022
Phase:
Study type: Observational [Patient Registry]

This study is a prospective observational chart review. The aim of the study is to evaluate tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for tricuspid regurgitation severity in comparison to VCA.

NCT ID: NCT03928639 Withdrawn - Heart Failure Clinical Trials

Structural Heart and Valve Network PROSPECTIVE Registry

Start date: January 10, 2023
Phase:
Study type: Observational

Background: Treatments for structural heart and valve disease are quickly changing. But treatment could be improved. Researchers want to gather data from people with this disease. They want to find problems and seek new ways to make treatments better. Objective: To find people with structural heart and valve disease with common features to study. To find flaws and patterns in procedures related to this disease. To share findings with other researchers. Eligibility: People ages 18 and older who are receiving care from the structural heart and valve program at the participating NHLBI structural heart disease network sites that are part of the study Design: Participants will be screened with their consent. This will occur when they give their standard consent for medical care. Participants will have their data collected in the course of standard medical care. Data include: Demographic data Protected health data Personally identifiable data Medical records Medical images. These could include X-rays, CT scans, and MRI scans. The study could find something that would impact participants care. If this is the case, their doctors will be told. Participants data may be shared with other researchers. ...

NCT ID: NCT03166488 Withdrawn - Clinical trials for Tricuspid Valve Insufficiency

MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to look at liver stiffness with a MRI sequence called Magnetic Resonance Elastography (MRE). The study will let the investigators know whether the subject's liver is normal or has increased stiffness. Increased liver stiffness often means there is chronic liver disease and fibrosis. Increased right heart pressure and congestive heart failure are considered risk factors for development of liver fibrosis. Liver fibrosis, if progressive, may lead to cirrhosis and its related complications. The increased liver stiffness may be due to a poorly functioning tricuspid valve. With this research, the investigators will be able to determine if the elevated stiffness of the liver returns to normal after the surgeon performs a repair or replacement of the tricuspid valve.

NCT ID: NCT02560116 Withdrawn - Clinical trials for Hypertension, Pulmonary

The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals

Start date: June 2015
Phase: N/A
Study type: Observational

The investigators aim to correlate noninvasive pulmonary artery systolic pressure (PASP) measurements obtained with and without echocardiographic contrast (Optison) during transthoracic echocardiography (TTE) with those obtained invasively and simultaneously during right heart catheterization, as the gold standard.